BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32155034)

  • 1. SOX10 commonly stains scar in Mohs sections.
    Donaldson MR; Weber LA
    Dermatol Online J; 2020 Jan; 26(1):. PubMed ID: 32155034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
    Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
    J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Immunostaining With SOX10 and AE1/AE3 to Confirm Perineural Invasion on Mohs Sections.
    Donaldson MR; Weber A
    J Drugs Dermatol; 2019 Mar; 18(3):262-264. PubMed ID: 30909330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX-10 staining in dermal scars.
    Behrens EL; Boothe W; D'Silva N; Walterscheid B; Watkins P; Tarbox M
    J Cutan Pathol; 2019 Aug; 46(8):579-585. PubMed ID: 30950082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MITF, SOX10, MART-1, and R21 Immunostaining for the Diagnosis of Residual Melanoma In Situ on Chronically Sun-Damaged Skin.
    Mu EW; Quatrano NA; Yagerman SE; Ratner D; Meehan SA
    Dermatol Surg; 2018 Jul; 44(7):933-938. PubMed ID: 29419543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
    Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
    J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor.
    Glass LF; Raziano RM; Clark GS; Higgins HW; Ladd S; Lien MH; Chen R; Cherpelis BS
    Am J Dermatopathol; 2010 Jun; 32(4):319-25. PubMed ID: 20514666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic performance of melanocytic markers for immunocytochemical evaluation of lymph-node melanoma metastases on cytological samples.
    Ronchi A; Zito Marino F; Toni G; Pagliuca F; Russo D; Signoriello G; Moscarella E; Brancaccio G; Argenziano G; Franco R; Cozzolino I
    J Clin Pathol; 2022 Jan; 75(1):45-49. PubMed ID: 33509946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
    Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
    Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX10 Immunostaining in granulomatous dermatoses and benign reactive lymph nodes.
    Merelo Alcocer V; Flamm A; Chen G; Helm K
    J Cutan Pathol; 2019 Aug; 46(8):586-590. PubMed ID: 30957251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Update and Review of Clinical Outcomes Using Immunohistochemical Stains in Mohs Micrographic Surgery for Melanoma.
    Elgash M; Young J; White K; Leitenberger J; Bar A
    Dermatol Surg; 2024 Jan; 50(1):9-15. PubMed ID: 37738278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special stains in Mohs surgery.
    Miller CJ; Sobanko JF; Zhu X; Nunnciato T; Urban CR
    Dermatol Clin; 2011 Apr; 29(2):273-86, ix. PubMed ID: 21421151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX10 expression in cutaneous scars: a potential diagnostic pitfall in the evaluation of melanoma re-excision specimens.
    Jackett LA; McCarthy SW; Scolyer RA
    Pathology; 2016 Oct; 48(6):626-8. PubMed ID: 27580960
    [No Abstract]   [Full Text] [Related]  

  • 14. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique.
    Albertini JG; Elston DM; Libow LF; Smith SB; Farley MF
    Dermatol Surg; 2002 Aug; 28(8):656-65. PubMed ID: 12174054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions.
    BrogÄrd MB; Nielsen PS; Christensen KB; Georgsen JB; Wandler A; Lade-Keller J; Steiniche T
    Pathol Res Pract; 2024 Mar; 255():155177. PubMed ID: 38330618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX10 expression in malignant melanoma, carcinoma, and normal tissues.
    Mohamed A; Gonzalez RS; Lawson D; Wang J; Cohen C
    Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):506-10. PubMed ID: 23197006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases.
    Buonaccorsi JN; Prieto VG; Torres-Cabala C; Suster S; Plaza JA
    Am J Dermatopathol; 2014 Feb; 36(2):124-30. PubMed ID: 23782678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid SOX10 Immunostain on Fresh Frozen Tissue.
    Donaldson MR; Deeths MJ; Weber LA
    Dermatol Surg; 2016 Feb; 42(2):269-71. PubMed ID: 26808180
    [No Abstract]   [Full Text] [Related]  

  • 19. The accuracy of detecting melanoma on frozen section melanoma antigen recognized by T cells 1 (MART-1) stains and on permanent sections of previously frozen tissue: A prospective cohort study.
    Bhatt MD; Perz AM; Moioli E; Sobanko JF; Shin TM; Etzkorn JR; Elenitsas R; Chu EY; Higgins HW; Giordano CN; McMurray S; Krausz A; Aizman L; Lukowiak TM; Miller CJ
    J Am Acad Dermatol; 2021 Jun; 84(6):1764-1766. PubMed ID: 33453343
    [No Abstract]   [Full Text] [Related]  

  • 20. Histopathologic Characterization of Incidental Lesions Encountered During Mohs Micrographic Surgery With MART-1 Immunohistochemistry.
    Hirotsu KE; Kibbi N; Rieger KE; Aasi SZ
    Dermatol Surg; 2024 Mar; 50(3):234-240. PubMed ID: 38064448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.